Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Dai's Stock Ratings
UBS Analyst
David Dai is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/24/2025
Overall Average Return
-32.3%
Smart Score
Overall Average Return Percentile
7th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | NUVL | Buy Now | Nuvalent | $72.71 | 37.53% | David Dai26% | $100 → $100 | Upgrade | Neutral → Buy | Get Alert |
| 03/06/2025 | KURA | Buy Now | Kura Oncology | $6.37 | 119.78% | David Dai26% | $27 → $14 | Maintains | Buy | Get Alert |
| 10/24/2024 | IMCR | Buy Now | Immunocore Hldgs | $29.80 | -19.46% | David Dai26% | → $24 | Initiates | → Sell | Get Alert |
| 10/24/2024 | NUVL | Buy Now | Nuvalent | $72.71 | 37.53% | David Dai26% | → $100 | Initiates | → Neutral | Get Alert |
| 10/24/2024 | BPMC | Buy Now | Blueprint Medicines | $85.81 | 2.55% | David Dai26% | → $88 | Initiates | → Neutral | Get Alert |
| 10/24/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | David Dai26% | → $20 | Initiates | → Buy | Get Alert |
| 10/24/2024 | NRIX | Buy Now | Nurix Therapeutics | $11.71 | 198.89% | David Dai26% | → $35 | Initiates | → Buy | Get Alert |
| 10/24/2024 | MRUS | Buy Now | Merus | $41.83 | 72.13% | David Dai26% | → $72 | Initiates | → Buy | Get Alert |
| 10/24/2024 | KURA | Buy Now | Kura Oncology | $6.37 | 323.86% | David Dai26% | → $27 | Initiates | → Buy | Get Alert |
| 10/24/2024 | JANX | Buy Now | Janux Therapeutics | $31.62 | 118.22% | David Dai26% | → $69 | Initiates | → Buy | Get Alert |
| 10/24/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.82 | 165.67% | David Dai26% | → $50 | Initiates | → Buy | Get Alert |
| 10/24/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $3.20 | 431.25% | David Dai26% | → $17 | Initiates | → Buy | Get Alert |
| 10/24/2024 | CGEM | Buy Now | Cullinan Therapeutics | $8.38 | 258% | David Dai26% | → $30 | Initiates | → Buy | Get Alert |
| 10/24/2024 | CGON | Buy Now | CG Oncology | $20.58 | 191.55% | David Dai26% | → $60 | Initiates | → Buy | Get Alert |
| 10/24/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.00 | 184.62% | David Dai26% | → $37 | Initiates | → Buy | Get Alert |
| 02/24/2023 | JNCE | Buy Now | Jounce Therapeutics | — | — | David Dai26% | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/31/2022 | ACET | Buy Now | Adicet Bio | $0.57 | 4800.25% | David Dai26% | → $28 | Initiates | → Outperform | Get Alert |
| 03/16/2022 | INBX | Buy Now | Inhibrx | $12.16 | 228.95% | David Dai26% | → $40 | Initiates | → Outperform | Get Alert |
| 03/16/2022 | JNCE | Buy Now | Jounce Therapeutics | — | — | David Dai26% | → $17 | Initiates | → Outperform | Get Alert |
| 02/04/2022 | MGNX | Buy Now | Macrogenics | $1.71 | 2239.18% | David Dai26% | → $40 | Initiates | → Outperform | Get Alert |
| 11/18/2021 | NKTX | Buy Now | Nkarta | $2.18 | 2191.69% | David Dai26% | → $50 | Initiates | → Outperform | Get Alert |
| 03/17/2020 | JD | Buy Now | JD.com | $33.68 | 54.39% | David Dai26% | $41 → $52 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/25/2017 | SNE | Buy Now | Sony | — | — | David Dai26% | → $41 | Initiates | → Outperform | Get Alert |
